Search Results - "Tucker, Geoffrey T"

Refine Results
  1. 1

    Simulation and prediction of in vivo drug metabolism in human populations from in vitro data by Rostami-Hodjegan, Amin, Tucker, Geoffrey T

    Published in Nature reviews. Drug discovery (01-02-2007)
    “…The perceived failure of new drug development has been blamed on deficiencies in in vivo studies of drug efficacy and safety. Prior simulation of the potential…”
    Get full text
    Journal Article
  2. 2

    A Re-evaluation and Validation of Ontogeny Functions for Cytochrome P450 1A2 and 3A4 Based on In Vivo Data by Salem, Farzaneh, Johnson, Trevor N., Abduljalil, Khaled, Tucker, Geoffrey T., Rostami-Hodjegan, Amin

    Published in Clinical pharmacokinetics (01-07-2014)
    “…Background and Objectives Current cytochrome P450 (CYP) 1A2 and 3A4 ontogeny profiles, which are derived mainly from in vitro studies and incorporated in…”
    Get full text
    Journal Article
  3. 3

    Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children by JOHNSON, Trevor N, ROSTAMI-HODJEGAN, Amin, TUCKER, Geoffrey T

    Published in Clinical pharmacokinetics (01-01-2006)
    “…Prediction of the exposure of neonates, infants and children to xenobiotics is likely to be more successful using physiologically based pharmacokinetic models…”
    Get full text
    Journal Article
  4. 4

    Does age affect gastric emptying time? A model-based meta-analysis of data from premature neonates through to adults by Bonner, Jennifer J., Vajjah, Pavan, Abduljalil, Khaled, Jamei, Masoud, Rostami-Hodjegan, Amin, Tucker, Geoffrey T., Johnson, Trevor N.

    Published in Biopharmaceutics & drug disposition (01-05-2015)
    “…Purpose. Gastric emptying (GE) is often reported to be slower and more irregular in premature neonates than in older children and adults. The aim of this study…”
    Get full text
    Journal Article
  5. 5

    A Semi-Mechanistic Model to Predict the Effects of Liver Cirrhosis on Drug Clearance by Johnson, Trevor N., Boussery, Koen, Rowland-Yeo, Karen, Tucker, Geoffrey T., Rostami-Hodjegan, Amin

    Published in Clinical pharmacokinetics (01-03-2010)
    “…Background and Objective: Liver cirrhosis is characterized by a decrease in functional hepatocytes, lowered circulating levels of plasma proteins and…”
    Get full text
    Journal Article
  6. 6

    In Vitro Characterization of the Human Liver Microsomal Kinetics and Reaction Phenotyping of Olanzapine Metabolism by Korprasertthaworn, Porntipa, Polasek, Thomas M, Sorich, Michael J, McLachlan, Andrew J, Miners, John O, Tucker, Geoffrey T, Rowland, Andrew

    Published in Drug metabolism and disposition (01-11-2015)
    “…Olanzapine (OLZ) is an atypical antipsychotic used in the treatment of schizophrenia and related psychoses. The metabolism of OLZ is complex and incompletely…”
    Get full text
    Journal Article
  7. 7

    Assessment of algorithms for predicting drug–drug interactions via inhibition mechanisms: comparison of dynamic and static models by Guest, Eleanor J., Rowland‐Yeo, Karen, Rostami‐Hodjegan, Amin, Tucker, Geoffrey T., Houston, J. Brian, Galetin, Aleksandra

    Published in British journal of clinical pharmacology (01-01-2011)
    “…WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • The prediction of drug–drug interactions (DDIs) from in vitro data usually utilizes an average dosing interval…”
    Get full text
    Journal Article
  8. 8

    Personalized Drug Dosage – Closing the Loop by Tucker, Geoffrey T

    Published in Pharmaceutical research (01-08-2017)
    “…A brief account is given of various approaches to the individualization of drug dosage, including the use of pharmacodynamic markers, therapeutic monitoring of…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Differences in Cytochrome P450-Mediated Pharmacokinetics Between Chinese and Caucasian Populations Predicted by Mechanistic Physiologically Based Pharmacokinetic Modelling by Barter, Zoe E., Tucker, Geoffrey T., Rowland-Yeo, Karen

    Published in Clinical pharmacokinetics (01-12-2013)
    “…Background International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) guidelines emphasize the…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Letter to the editor about reporting drug concentrations and pharmacokinetics in regional anesthesia and pain medicine by Mather, Laurence E, Tucker, Geoffrey T

    Published in Regional anesthesia and pain medicine (05-02-2024)
    “…Whereas arterial blood drug concentrations, other than those in pulmonary vessels, will be essentially the same throughout the body, those in veins differ,…”
    Get full text
    Journal Article
  13. 13

    When Regional Anesthesia Met Pharmacokinetics by Mather, Laurence E., Tucker, Geoffrey T.

    Published in Anesthesiology (Philadelphia) (01-04-2022)
    “…Pharmacokinetics of Local Anaesthetic Agents. By Tucker GT, Mather LE. Br J Anaesth 1975; 47(suppl 1):213–24 Information derived from measurements of blood…”
    Get full text
    Journal Article
  14. 14

    Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA by Yang, Jiansong, Jamei, Masoud, Heydari, Amir, Yeo, Karen R., de la Torre, Rafael, Farré, Magí, Tucker, Geoffrey T., Rostami-Hodjegan, Amin

    Published in Journal of psychopharmacology (Oxford) (01-11-2006)
    “…The aim of this study was to model the in vivo kinetic consequences of mechanism-based inhibition (MBI) of CYP2D6 by 3,4 methylenedioxymethamphetamine (MDMA,…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemia by Miners, John O., Chau, Nuy, Rowland, Andrew, Burns, Kushari, McKinnon, Ross A., Mackenzie, Peter I., Tucker, Geoffrey T., Knights, Kathleen M., Kichenadasse, Ganessan

    Published in Biochemical pharmacology (01-04-2017)
    “…[Display omitted] Kinase inhibitors (KIs) are a rapidly expanding class of drugs used primarily for the treatment of cancer. Data relating to the inhibition of…”
    Get full text
    Journal Article
  17. 17
  18. 18

    The British Journal of Clinical Pharmacology: The first 50 years by Cremers, Serge, Tucker, Geoffrey T., Aronson, Jeffrey K., Ritter, James M., Cohen, Adam F.

    Published in British journal of clinical pharmacology (01-01-2024)
    “…The British Journal of Clinical Pharmacology celebrates its 50th anniversary of publication in 2023. Here four previous Editors‐in‐Chief and the current Editor…”
    Get full text
    Journal Article
  19. 19
  20. 20

    A series acceleration algorithm for the gamma-Pareto (type I) convolution and related functions of interest for pharmacokinetics by Wesolowski, Carl A., Alcorn, Jane, Tucker, Geoffrey T.

    “…The gamma-Pareto type I convolution (GPC type I) distribution, which has a power function tail, was recently shown to describe the disposition kinetics of…”
    Get full text
    Journal Article